EBV-associated malignancies remain a considerable problem in HIV-infected individuals, even in the era of HAART. Although EBV is a common factor, each disease has a unique pathogenesis. Study of these diseases reveals the viral proteins expressed in the malignancies that might contribute to the development of the disease as well as the molecular basis for pathogenesis. It is likely that this knowledge will contribute to the development of novel therapeutics that will result in more favorable outcomes in the future.
|Original language||English (US)|
|Number of pages||21|
|Journal||Cancer treatment and research|
|Publication status||Published - 2007|
All Science Journal Classification (ASJC) codes
- Cancer Research